TrialInternational journal of hematology2004

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Yasuo Morishima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.